Amanote Research
Register
Sign In
62. Modulating Transgenic Factor IX to Therapeutic Levels Following Low-Dose Administration of AAV in Fah-Deficient Mice
Molecular Therapy
- United States
doi 10.1016/s1525-0016(16)35075-4
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
May 1, 2014
Authors
Unknown
Publisher
Elsevier BV
Related search
Major Role of Local Immune Responses in Antibody Formation to Factor IX in AAV Gene Transfer
Gene Therapy
Molecular Medicine
Genetics
Molecular Biology
IX. Mast Cell-Deficient Mice and Intestinal Biology
American Journal of Physiology - Gastrointestinal and Liver Physiology
Hepatology
Physiology
Gastroenterology
Reduction in Insulin Sensitivity Following Administration of the Clinically Used Low-Dose Pressor, Norepinephrine
Diabetes/Metabolism Research and Reviews
Internal Medicine
Endocrinology
Metabolism
Diabetes
Inhibition of HBV Expression in HBV Transgenic Mice Using AAV-Delivered CRISPR-SaCas9
Frontiers in Immunology
Allergy
Immunology
Microcephaly Due to Low-Dose Intrauterine Radiation Exposure Caused by 33P Β Administration to Pregnant Mice
RADIOISOTOPES
Leukemia/Lymphoma Development in IL-15-deficient TCR-transgenic Mice
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Effect of Low-Dose Aspirin on Vascular Inflammation, Plaque Stability, and Atherogenesis in Low-Density Lipoprotein Receptor-Deficient Mice
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Therapeutic Effects of PKC Activators in Alzheimer's Disease Transgenic Mice
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Macrophage Migration Inhibitory Factor Deficiency Impairs Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice
Circulation
Cardiovascular Medicine
Physiology
Cardiology
